导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.86% | 294/1050 |
| 近一周 | -2.94% | 915/1104 |
| 近一月 | -3.61% | 622/1103 |
| 近一季 | -2.86% | 390/1092 |
| 近半年 | 8.50% | 277/1070 |
| 近一年 | 14.82% | 307/1018 |
| 近两年 | 78.07% | 322/926 |
| 近三年 | 57.46% | 225/834 |
| 成立以来 | 120.86% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.34% 673/1070 |
18.17% 405/1101 |
- - |
- - |
| 2025 | 40.92% 309/1065 |
6.10% 333/1014 |
3.31% 412/1038 |
33.16% 316/1050 |
-3.45% 631/1065 |
| 2024 | 13.24% 212/1011 |
3.23% 156/960 |
4.67% 109/983 |
8.72% 739/991 |
-3.61% 579/1011 |
| 2023 | -23.84% 757/952 |
-1.73% 695/880 |
-6.54% 612/895 |
-7.94% 494/915 |
-9.93% 855/952 |
| 2022 | -29.76% 624/867 |
-19.82% 508/773 |
5.64% 482/806 |
-16.83% 673/845 |
-0.28% 455/867 |
| 2021 | -0.83% 363/740 |
5.92% 42/580 |
6.34% 443/659 |
-7.62% 444/704 |
-4.69% 587/740 |
| 2020 | 67.98% 149/554 |
-2.94% 234/419 |
27.70% 150/466 |
14.75% 147/517 |
18.11% 151/554 |
| 2019 | 55.18% 112/410 |
25.36% 681/1146 |
0.58% 277/1228 |
10.59% 103/390 |
11.28% 125/410 |
| 2018 | -16.07% 34/349 |
- - |
-2.78% 138/990 |
-8.76% 691/1000 |
-8.17% 160/1080 |
| 2017 | 28.17% 48/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国富沪港深成长精选股票A VS. 东吴新产业精选股票A(580008) |